Wells Fargo’s Gilead Sciences GILD Stock Holding History

Wells Fargo’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.37M	Buy	17,000 +1,500	+10%	+$210K	﹤0.01%	3141
2025 Q4	$1.9M	Sell	15,500 -2,000	-11%	-$243K	﹤0.01%	3484
2025 Q3	$1.94M	Hold	17,500	–	–	﹤0.01%	3329
2025 Q2	$1.94M	Hold	17,500	–	–	﹤0.01%	3235
2025 Q1	$1.96M	Buy	+17,500	New	+$1.81M	﹤0.01%	3173
2024 Q2	–	Sell	-3,800	Closed	-$278K	–	7107
2024 Q1	$278K	Sell	3,800 -1,000	-21%	-$76.9K	﹤0.01%	4261
2023 Q4	$389K	Hold	4,800	–	–	﹤0.01%	4027
2023 Q3	$360K	Hold	4,800	–	–	﹤0.01%	3977
2023 Q2	$370K	Buy	+4,800	New	+$383K	﹤0.01%	4163
2022 Q2	–	Sell	-3,000	Closed	-$178K	–	7040
2022 Q1	$178K	Sell	3,000 -8,600	-74%	-$550K	﹤0.01%	5046
2021 Q4	$842K	Buy	11,600 +3,600	+45%	+$248K	﹤0.01%	4255
2021 Q3	$559K	Sell	8,000 -51,000	-86%	-$3.58M	﹤0.01%	4604
2021 Q2	$4.06M	Buy	59,000 +53,400	+954%	+$3.57M	﹤0.01%	3039
2021 Q1	$362K	Buy	+5,600	New	+$361K	﹤0.01%	4865
2020 Q4	–	Sell	-3,500	Closed	-$4K	–	6664
2020 Q3	$4K	Buy	3,500 +2,000	+133%	+$139K	﹤0.01%	6045
2020 Q2	$1K	Sell	1,500 -95,900	-98%	-$7.35M	﹤0.01%	6164
2020 Q1	$316K	Buy	97,400 +95,100	+4,135%	+$6.57M	﹤0.01%	4380
2019 Q4	$3K	Sell	2,300 -42,700	-95%	-$2.78M	﹤0.01%	6114
2019 Q3	$84K	Sell	45,000 -5,000	-10%	-$327K	﹤0.01%	5389
2019 Q2	$72K	Buy	50,000 +14,300	+40%	+$941K	﹤0.01%	5429
2019 Q1	$19K	Sell	35,700 -52,100	-59%	-$3.46M	﹤0.01%	5542
2018 Q4	$86K	Buy	+87,800	New	+$6.14M	﹤0.01%	5353
2018 Q2	–	Sell	-13,400	Closed	-$50K	–	6405
2018 Q1	$50K	Sell	13,400 -120,000	-90%	-$9.54M	﹤0.01%	5564
2017 Q4	$1.48M	Buy	133,400 +50,000	+60%	+$3.8M	﹤0.01%	3619
2017 Q3	$584K	Buy	83,400 +13,400	+19%	+$1.02M	﹤0.01%	4227
2017 Q2	$1.18M	Sell	70,000 -145,000	-67%	-$9.65M	﹤0.01%	3618
2017 Q1	$1.93M	Sell	215,000 -32,500	-13%	-$2.29M	﹤0.01%	3236
2016 Q4	$3.39M	Buy	247,500 +37,000	+18%	+$2.75M	﹤0.01%	2717
2016 Q3	$3.47M	Buy	210,500 +7,000	+3%	+$569K	﹤0.01%	2543
2016 Q2	$3.01M	Sell	203,500 -42,000	-17%	-$3.73M	﹤0.01%	2681
2016 Q1	$2.08M	Sell	245,500 -779,200	-76%	-$70.3M	﹤0.01%	2891
2015 Q4	$5.85M	Buy	1,024,700 +125,000	+14%	+$13M	﹤0.01%	2217
2015 Q3	$9.13M	Buy	899,700 +47,200	+6%	+$5.24M	﹤0.01%	1873
2015 Q2	$3.15M	Buy	852,500 +51,200	+6%	+$5.59M	﹤0.01%	2751
2015 Q1	$3.51M	Buy	801,300 +375,300	+88%	+$38.1M	﹤0.01%	2622
2014 Q4	$3.8M	Buy	426,000 +274,700	+182%	+$28.4M	﹤0.01%	2551
2014 Q3	$723K	Buy	151,300 +148,200	+4,781%	+$14.5M	﹤0.01%	3670
2014 Q2	$3K	Buy	3,100 +2,900	+1,450%	+$226K	﹤0.01%	5885
2014 Q1	$1K	Buy	+200	New	+$15.7K	﹤0.01%	5761
2013 Q3	–	Sell	-400	Closed	-$1K	–	5716
2013 Q2	$1K	Buy	+400	New	+$20.8K	﹤0.01%	5454

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wells Fargo's GILD Position: Q1 2026 in Review

Wells Fargo reduced its Gilead Sciences (GILD) stake by 0.31% in Q1 2026, selling an estimated $2.9M and leaving 6,628,441 shares worth $924M. The position accounts for 0.17% of the portfolio, ranked #121.

Wells Fargo first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.59B in Q2 2015. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Wells Fargo held 6,628,441 shares of Gilead Sciences worth $924M as of Q1 2026.
Wells Fargo sold 20,734 Gilead Sciences shares in Q1 2026, an estimated $2.9M.
Gilead Sciences made up 0.17% of Wells Fargo's portfolio in Q1 2026, its #121 holding.
Wells Fargo first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
Wells Fargo's Gilead Sciences position peaked at $1.59B in Q2 2015.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.